Blood eosinophilic relative count is prognostic for breast cancer and associated with the presence of tumor at diagnosis and at time of relapse

Blood eosinophilic relative count is prognostic for breast cancer and associated with the presence of tumor at diagnosis and at time of relapse

Background Cancer outcome is associated with circulating immune cells, including eosinophils. Here we analyze the relative eosinophil count (REC) in different breast cancer subtypes. Methods Stage I–III breast cancer patients were included in the study and classified as REC-high vs low (cutoff 1.5%)...

Full description

Bibliographic Details
Main Authors: Concetta Elisa Onesti, Claire Josse, Delphine Boulet, Jérôme Thiry, Barbara Beaumecker, Vincent Bours, Guy Jerusalem
Format: Article
Language:English
Published: Taylor & Francis Group 2020-01-01
Series:OncoImmunology
Subjects:
eosinophil
breast cancer
immune system
immune biomarker
lymphocyte
Online Access:http://dx.doi.org/10.1080/2162402X.2020.1761176

Internet

http://dx.doi.org/10.1080/2162402X.2020.1761176

Similar Items